Popular Articles

Obama Says He Supports 'Robust' Protections For Health Workers With Moral, Religious Objections
President Obama on Friday said that although he intends to reverse the Bush administration"s provider "conscience" rule, he still favors a "robust" federal policy that would enhance the rights of health care workers to refuse to perform certain procedures because of moral or religious objections, the Washington Post reports. In a session with reporters one week before his first meeting with Pope Benedict XVI, Obama said that he is a "believer in conscience clauses." He added that a new policy from his administration "may not meet the criteria of every possible critic of our approach, but it certainly will not be weaker than what existed before the changes were made." According to the Post, Obama"s comments aimed to reassure Roman Catholic health care workers that they would still be able to refuse to perform abortions and other procedures that go against the Church"s teachings. Several federal laws in place since the 1970s protect the rights of health care workers with moral or religious objections (Salmon, Washington Post, 7/3). Nancy Berlinger, deputy director of the Hastings Center, said that conscience laws also "are on the books in almost every state." She added, "The idea was that when abortion moved from being an illegal procedure, therefore something that you did not offer in a hospital, to being a legal procedure, therefore something that you might offer in a hospital, there was a move to protect providers ... from having to participate in abortions." However, not all conscience laws are specific to abortion, NPR"s "Morning Edition" reports. For example, some allow providers to refuse to provide birth control, in vitro fertilization or end-of-life care (Rovner, "Morning Edition," NPR, 7/6).The Bush administration said its 2008 policy was designed to ensure that the federal laws are enforced. The policy would cut off federal funding to health care facilities and other entities that did not accommodate workers who refused to participate in certain procedures (Washington Post, 7/3). Joxel Garcia, the assistant secretary for health in the Bush administration who helped write the policy, said that it is necessary because few health care workers are aware of the protections. He added that the policy gives health workers "a mechanism to seek help" through HHS.However, critics of the Bush administration"s policy contend that it would widely expand the scope of health care covered by the policy and the type of health care workers who could object to procedures. Berlinger said, "Words like belief, when you talk about them in the context of health care, aren"t just anything you might think of." She noted that a "false belief about science or the promotion of ambiguity where things can be disambiguated," such as the claim that birth control is equivalent to abortion, "is not ethical" ("Morning Edition," NPR, 7/6).Obama"s plan to replace the policy has stoked concern from Catholic health care providers that they would be forced to perform abortions, sterilizations and other procedures that go against Catholic teachings (Washington Post, 7/3). A recent survey conducted for the Christian Medical Association found that 90% of doctors surveyed said that "they will quit their practices before violating their conscience," according to David Stevens, executive director of CMA. Stevens said that repealing the Bush administration"s rule "sends a clear message: It"s open season on health care professionals of conscience -- discriminate at will" ("Morning Edition," NPR, 7/6).Obama on Friday also said that although he and the pope have areas of "deep agreement ... there are going to be some areas where we"ve got some disagreements," such as abortion rights and embryonic stem cell research. The president will meet with the pope on July 10, while he is in Europe for a summit of the Group of Eight industrialized nations. Obama Addresses Catholic Concerns on Pregnancy PreventionObama also discussed opposition to the inclusion of comprehensive sex education and contraception in any legislative pac
generic viagra online
Study Identifies How Tamoxifen Stimulates Uterine Cell Growth And Cancer
UCSF researchers have identified a new "feed-forward" pathway linking estrogen receptors in the membrane of the uterus to a process that increases local estrogen levels and promotes cell growth.
News of the day
Social Care Workforce Not Ready To Deliver Dementia Care - MPs
A report published revealed the social care workforce is unfit to deliver quality care for people with dementia.
Diagnostics

Data Presented At The 5th International AIDS Society Conference Suggests Low Testosterone Frequently Goes Undetected In HIV-Positive Men

Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, announced that new data from the two-part HYHYHI Study (Hypogonadal Hypotestosteronism in HIV-Seropositive Men) were presented as a poster today at the 5th International AIDS Society (IAS) Conference in Cape Town, South Africa. This retrospective chart review, supported by the Company, evaluated the challenges associated with diagnosing low testosterone in men with HIV/AIDS. The study also compared the difference in testosterone levels achieved after 12 months of treatment with either Testim® 1% (testosterone gel) or AndroGel®, two commonly used FDA-approved testosterone replacement products. Results from the study showed that when using the more sensitive Free Testosterone test (FT About the Study The HYHYHI study, designed and conducted by Dr. Blick, was a retrospective chart review of men with HIV/AIDS screened for Low T and treated with testosterone replacement therapy. Data were collected from two U.S. sites and included 400 men diagnosed with HIV/AIDS and screened for Low T, defined as Total T About Testim Testim is a proprietary, clear, topical gel containing 1% testosterone, the same type of hormone that is produced by the human body. When applied once-daily to the upper arms and shoulders, clinical studies have shown that Testim will restore and maintain testosterone levels. Once Testim is absorbed through the skin, it enters the bloodstream and helps return testosterone to normal levels. The efficacy of Testim has been demonstrated in 16 clinical studies involving approximately 1,800 patients, including the largest placebo-controlled study ever conducted to evaluate the benefits and risks of testosterone replacement therapy. Auxilium estimates that approximately 76 million tubes, or daily applications, of Testim have been used since the product was launched in 2003. For information regarding the safety and use of Testim, please see the prescribing information at http://www.testim.com. Auxilium Pharmaceuticals, Inc.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):